荃信生物-B(02509.HK)11月19日耗资200万港元回购9.7万股

Core Viewpoint - The company, Qianxin Biotechnology-B (02509.HK), announced a share buyback of 97,000 shares at a cost of HKD 2 million on November 19 [1] Summary by Categories - Company Actions - The company executed a buyback of 97,000 shares, indicating a commitment to enhancing shareholder value [1] - The total expenditure for this buyback was HKD 2 million, reflecting the company's financial strategy [1]